Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
NCT ID:
NCT04126733
Group ID:
EG000
Title:
Regorafenib Plus Nivolumab
Description:
Regorafenib was administrated 2x40mg q.d. (cycle 1) then up to 3x40mg q.d. (from cycle 2 onward) for 3 weeks of each 28 days treatment cycle. Nivolumab was administrated 480mg on day 1 of each 28 days treatment cycle.
Deaths Number Affected:
40
Deaths Number At Risk:
None
Serious Number Affected:
34
Serious Number At Risk:
70
Other Number Affected:
66
Other Number At Risk:
70
Study:
NCT04126733
Results Section:
NCT04126733
Adverse Events Module:
NCT04126733